Literature DB >> 9505083

[Lipoproteins and diabetic nephropathy].

T Bertsch, J Aufenanger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9505083     DOI: 10.1007/BF03045044

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


× No keyword cloud information.
  12 in total

1.  Effect of serum amyloid A on cellular affinity of low density lipoprotein.

Authors:  T Yamada; T Miida; T Yamaguchi; Y Itoh
Journal:  Eur J Clin Chem Clin Biochem       Date:  1997-06

Review 2.  Advanced glycation end products, oxidant stress and vascular lesions.

Authors:  O Chappey; C Dosquet; M P Wautier; J L Wautier
Journal:  Eur J Clin Invest       Date:  1997-02       Impact factor: 4.686

3.  Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions.

Authors:  T Yamada; T Kakihara; T Kamishima; T Fukuda; T Kawai
Journal:  Pathol Int       Date:  1996-10       Impact factor: 2.534

4.  Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function.

Authors:  R Kisilevsky; L Subrahmanyan
Journal:  Lab Invest       Date:  1992-06       Impact factor: 5.662

Review 5.  Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice.

Authors:  E Malle; F C De Beer
Journal:  Eur J Clin Invest       Date:  1996-06       Impact factor: 4.686

6.  Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.

Authors:  T Jensen; S Stender; T Deckert
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

7.  The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes.

Authors:  M Morohoshi; K Fujisawa; I Uchimura; F Numano
Journal:  Ann N Y Acad Sci       Date:  1995-01-17       Impact factor: 5.691

8.  Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function.

Authors:  R L Meek; S Urieli-Shoval; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus.

Authors:  Y Kumon; T Suehiro; T Itahara; Y Ikeda; K Hashimoto
Journal:  Clin Biochem       Date:  1994-12       Impact factor: 3.281

10.  Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes.

Authors:  R Badolato; J M Wang; W J Murphy; A R Lloyd; D F Michiel; L L Bausserman; D J Kelvin; J J Oppenheim
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.